3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
4
Active not recruiting
4
Unknown
2
Withdrawn
1
Recruiting
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Interventions
olaparib
1
durvalumab
1
apatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Small Cell Lung Carcinoma
×
olaparib
×
Clear all
NCT06419179
2025-05-20
GUIDANCE
University of Cologne
Phase 2
Enrolling by invitation
29 enrolled